P T Williams1. 1. Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, Calif, USA. PTWilliams@LBL.gov
Abstract
BACKGROUND: Official guidelines from the Centers for Disease Control and Prevention and the American College of Sports Medicine state that every adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably all, days of the week. OBJECTIVE: To examine the dose-response relationship between coronary heart disease (CHD) risk factors and vigorous exercise above the recommended minimum levels to assess whether further benefits accrue. METHODS: Physician-supplied medical data were compared with reported distance run in a national cross-sectional survey of 8283 male recreational runners. RESULTS: Compared with runners who ran less than 16 km (10 miles) per week, long-distance runners (> or = 80 km/wk) showed an 85% reduced prevalence of high-density lipoprotein cholesterol levels that were clinically low (< 0.9 mmol/L [< 35 mg/dL]), a 2.5-fold increased prevalence of clinically defined high levels of high-density lipoprotein cholesterol (ie, > or = 1.55 mmol/L [> or = 60 mg/dL], the level thought to be protective against CHD), a nearly 50% reduction in hypertension, and more than a 50% reduction in the use of medications to lower blood pressure and plasma cholesterol levels. Estimated age-adjusted 10-year CHD risk was 30% lower in runners who averaged more than 64 km/wk than in those who averaged less than 16 km/wk (42 vs 61 events per 1000 men). Each 16-km incremental increase in weekly distance run up to 64 to 79 km/wk was associated with significant increases in high-density lipoprotein cholesterol levels and significant decreases in adiposity, triglyceride levels, the ratio of total cholesterol to high-density lipoprotein cholesterol level, and estimated CHD risk. CONCLUSIONS: Our data (1) suggest that substantial health benefits occur at exercise levels that exceed current minimum guidelines and (2) do not exhibit a point of diminishing return to the health benefits of running at any distance less than 80 km/wk.
BACKGROUND: Official guidelines from the Centers for Disease Control and Prevention and the American College of Sports Medicine state that every adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably all, days of the week. OBJECTIVE: To examine the dose-response relationship between coronary heart disease (CHD) risk factors and vigorous exercise above the recommended minimum levels to assess whether further benefits accrue. METHODS: Physician-supplied medical data were compared with reported distance run in a national cross-sectional survey of 8283 male recreational runners. RESULTS: Compared with runners who ran less than 16 km (10 miles) per week, long-distance runners (> or = 80 km/wk) showed an 85% reduced prevalence of high-density lipoprotein cholesterol levels that were clinically low (< 0.9 mmol/L [< 35 mg/dL]), a 2.5-fold increased prevalence of clinically defined high levels of high-density lipoprotein cholesterol (ie, > or = 1.55 mmol/L [> or = 60 mg/dL], the level thought to be protective against CHD), a nearly 50% reduction in hypertension, and more than a 50% reduction in the use of medications to lower blood pressure and plasma cholesterol levels. Estimated age-adjusted 10-year CHD risk was 30% lower in runners who averaged more than 64 km/wk than in those who averaged less than 16 km/wk (42 vs 61 events per 1000 men). Each 16-km incremental increase in weekly distance run up to 64 to 79 km/wk was associated with significant increases in high-density lipoprotein cholesterol levels and significant decreases in adiposity, triglyceride levels, the ratio of total cholesterol to high-density lipoprotein cholesterol level, and estimated CHD risk. CONCLUSIONS: Our data (1) suggest that substantial health benefits occur at exercise levels that exceed current minimum guidelines and (2) do not exhibit a point of diminishing return to the health benefits of running at any distance less than 80 km/wk.
Authors: A R Folsom; C J Caspersen; H L Taylor; D R Jacobs; R V Luepker; O Gomez-Marin; R F Gillum; H Blackburn Journal: Am J Epidemiol Date: 1985-04 Impact factor: 4.897
Authors: W L Haskell; C Camargo; P T Williams; K M Vranizan; R M Krauss; F T Lindgren; P D Wood Journal: N Engl J Med Date: 1984-03-29 Impact factor: 91.245
Authors: Wendy M Miller; Katherine E Nori-Janosz; Martin Lillystone; Jose Yanez; Peter A McCullough Journal: Curr Cardiol Rep Date: 2005-11 Impact factor: 2.931
Authors: Therese Hornstrup; F T Løwenstein; M A Larsen; E W Helge; S Póvoas; J W Helge; J J Nielsen; B Fristrup; J L Andersen; L Gliemann; L Nybo; P Krustrup Journal: Eur J Appl Physiol Date: 2018-11-24 Impact factor: 3.078
Authors: Francis M Finucane; Jessica Horton; Lisa R Purslow; David B Savage; Soren Brage; Hervé Besson; Kenneth Horton; Ema De Lucia Rolfe; Alison Sleigh; Stephen J Sharp; Helen J Martin; Avan Aihie Sayer; Cyrus Cooper; Ulf Ekelund; Simon J Griffin; Nicholas J Wareham Journal: BMC Endocr Disord Date: 2009-06-19 Impact factor: 2.763